BoobyBiome, a female-founded deep tech startup spun out of College Faculty London’s Nice Ormond Avenue Institute of Little one Well being, has secured £2.5 million in seed funding to deal with a essential however typically neglected problem in toddler vitamin: preserving the helpful microbiome in expressed breast milk and supplementing formula-fed infants with key bacterial strains.
The £2.5 million seed spherical was led by specialist deep tech investor Empirical Ventures, with backing from The Helm, XFactor Ventures, Lavender Ventures, Kayan Ventures, Evenlode Funding, and angel buyers together with Dominic Hollamby and Lord Ara Darzi.
The corporate’s analysis revealed that helpful micro organism, important for toddler immune growth, start to perish inside 20 minutes of publicity to oxygen after breast milk is expressed. This perception drove the event of a patented storage system that mimics the low-oxygen circumstances of the breast, preserving not solely the stay microbiome but additionally very important antioxidants and nutritional vitamins. These parts are essential in defending infants in opposition to widespread early-life circumstances corresponding to bronchial asthma, meals allergy symptoms, kind 1 diabetes, and weight problems.
Dr Ben Miles, Basic Accomplice at Empirical Ventures, added, “We’re proud to assist the good group at BoobyBiome as they advance their analysis and produce their groundbreaking know-how to market. Lydia, Sioned, and Tara’s mixed experience makes them exceptionally properly positioned to remodel toddler well being, addressing a essential hole that has been neglected for too lengthy.”
Based in 2019 by microbiologists Dr Lydia Mapstone (CEO), Dr Sioned Jones (COO), and Dr Tara O’Driscoll (CTO), BoobyBiome builds on 5 years of rigorous microbiome analysis. Their know-how leverages the world’s largest high-resolution breast milk microbiome database together with a biobank of proprietary bacterial strains.
Collectively, these underpin two complementary improvements: an oxygen-excluding storage system suitable with any toddler bottle, and a stay microbiome drop designed to complement components, in addition to feeding for C-section and preterm infants whose microbiomes could also be underdeveloped.
BoobyBiome plans to launch its storage system on to customers within the UK in 2026, with subsequent growth to European and US markets. Concurrently, medical trials are underway to validate the security and efficacy of their stay microbiome drop. The most recent funding will speed up the corporate’s world business scaling, assist partnerships with toddler bottle producers, and additional its scientific analysis.
